Literature DB >> 14292999

TRANSDUCTION OF STAPHYLOCOCCUS AUREUS TO TETRACYCLINE RESISTANCE IN VIVO.

H JAROLMEN, A BONDI, R L CROWELL.   

Abstract

Jarolmen, Howard (Hahnemann Medical College, Philadelphia, Pa.), Amedeo Bondi, and Richard L. Crowell. Transduction of Staphylococcus aureus to tetracycline resistance in vivo. J. Bacteriol. 89:1286-1290. 1965.-Staphylophage 80, propagated on a hospital strain of Staphylococcus aureus 80/81, has been shown to transduce antibiotic resistance markers to a variety of staphylococcal recipient strains in vitro. In an attempt to demonstrate transduction of penicillin and tetracycline resistance in mice, experiments were performed in which mice were injected intravenously with a pathogenic recipient strain, S. aureus N135, and subsequently with transducing phage by the same route. Periodic assays of organs from infected mice revealed that maximal bacterial concentrations were attained in kidneys 6 days after infection, at which time the transducing lysate, containing approximately 5 x 10(10) plaque-forming particles, was introduced. Isolation of tetracycline-resistant transductants from the kidneys of infected animals was facilitated by the therapeutic administration of tetracycline. In contrast, penicillin-resistant transductants, which produced penicillinase, were not found even when penicillin therapy was administered. Results showed that tetracycline-resistant transductants were recovered from as many as 40% of test animals in repeated experiments. Furthermore, in some of these mice the entire staphylococcal population of the kidneys was found to be tetracycline-resistant. Control infected animals which did not receive phage were uniformly negative for tetracycline-resistant staphylococci. The finding that phage levels were low or undetectable at a time when tetracycline-resistant organisms were recovered from test animals provided evidence that transduction had occurred in vivo.

Entities:  

Keywords:  DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; GENETICS; INJECTIONS, INTRAVENOUS; KIDNEY; MICE; PENICILLIN; PENICILLIN RESISTANCE; PHARMACOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PHAGES; STAPHYLOCOCCUS; TETRACYCLINE

Mesh:

Substances:

Year:  1965        PMID: 14292999      PMCID: PMC277641          DOI: 10.1128/jb.89.5.1286-1290.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  5 in total

1.  Transduction of capacity to produce staphylococcal penicillinase.

Authors:  H L RITZ; J N BALDWIN
Journal:  Proc Soc Exp Biol Med       Date:  1961-07

2.  TRANSDUCTION BY STAPHYLOCOCCAL BACTERIOPHAGE.

Authors:  M L Morse
Journal:  Proc Natl Acad Sci U S A       Date:  1959-05       Impact factor: 11.205

3.  Agar layer method for production of high titer phage stocks.

Authors:  M SWANSTROM; M H ADAMS
Journal:  Proc Soc Exp Biol Med       Date:  1951-11

4.  Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.

Authors:  P A PATTEE; J N BALDWIN
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

5.  Transduction of resistance to chlortetracycline and novobiocin in Staphylococcus aureus.

Authors:  P A PATTEE; J N BALDWIN
Journal:  J Bacteriol       Date:  1961-12       Impact factor: 3.490

  5 in total
  5 in total

1.  Actual status of mutageneity testing with the host-mediated assay.

Authors:  G R Mohn
Journal:  Arch Toxicol       Date:  1977-09-21       Impact factor: 5.153

2.  Prevention of staphylococcal bacteriophage activity by antigen A precipitins in human sera.

Authors:  R R Martin; A White
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

3.  Transfer of infectious drug resistance in microbially defined mice.

Authors:  N D Reed; D G Sieckmann; C E Georgi
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

4.  Stability of neomycin resistance in Staphylococcus aureus.

Authors:  G A Ayliffe
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

5.  In vivo transmission of drug resistance factors between strains of Staphylococcus aureus.

Authors:  R P Novick; S I Morse
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.